Fundamentally, the BCS is a scientific framework for classifying drug substances (i.e. Since it was introduced in 1995, the Biopharmaceutics Classification System (BCS) has had a major impact on the regulation of oral drug products worldwide. other similar classification systems as well as regulatory issues that impact the BCS such as global harmonisation, public release of data (i.e., transparency), and quality by design the role for biopharmaceutical companies the relative strengths and weaknesses of the BCS vs. The article talks about the status of BCS and BCS-analogues in Asia-Pacific countries the role of the BCS for generic companies vs. Along with Regulatory authorities, pharmaceutical manufacturers are also making use of BCS throughout drug discovery and development processes.
0 kommentar(er)
